FDA 483 - ACI HealthCare Limited - April 06, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
ACI HealthCare Limited, a drug product manufacturer in Narayanganj, Bangladesh, was cited for failing to store drug products under appropriate temperature and humidity conditions. The inspection revealed deficiencies in the firm's warehouse temperature mapping studies for both finished drug products and raw materials, as the studies did not represent worst-case summer temperatures. This raises concerns about the identity, strength, quality, and purity of the stored products.
ID · cbaecdc7-a1d3-449b-8108-f945891a054e